Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Braskem S.A. (BRKM5.SA)
São Paulo, SP, BR
Braskem S.A., together with its subsidiaries, engages in the manufacture, sale, import, and export of chemicals, petrochemicals, and fuels in Brazil. It produces and sells polyethylene (PE), polypropylene, tertiary-butyl ethyl ether, gasoline, benzene, toluene, xylene, ethylene, propylene, polyvinyl chloride, caustic soda, butadiene, cumene, naphtha, solvents, and condensate; thermoplastic resins; and basic petrochemicals. The company also supplies electricity and other inputs to second-generation producers; and sale of utilities such as steam, water, compressed air and industrial gases, as well as provides industrial services and natural gas. It also operates in the United States, Mexico, Switzerland, Argentina, Germany, Japan, the Netherlands, Singapore, Chile, Spain, Peru, Italy, Luxembourg, China, and internationally. The company was formerly known as Copene Petroquímica do Nordeste S.A. and changed its name to Braskem S.A. in 2002. Braskem S.A. was founded in 1972 and is headquartered in São Paulo, Brazil. Braskem S.A. is a subsidiary of NSP Investimentos S.A.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.49% | +35.67% | +37.97% | +22.59% | +55.34% | +57.55% | +16.40% | -47.75% | -77.39% | -44.60% | +187.97% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 8 | -1 |
| Sell | 1 | 0 |
| Strong Sell | 1 | 0 |
-
Revenue growth Chemicals: +4.0%-8.7% Q1'26: -20.4% (vs Q1'25)
-
EPS growth Chemicals: +11.7%+12.8% ★ Q1'26: +105.7% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%-25.9% Q1'26: -31.8% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%-5.7% Q1'26: -2.0% (vs Q1'25)
-
ROIC Chemicals: +3.4%-9.4% Q1'26: -2.7% (vs Q1'25)
-
Share dilution Chemicals: +0.0%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×110.74× Q1'26: 19.60× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 1 EPS Ana. |
Dec 2027 8 Rev. Ana. 1 EPS Ana. |
Dec 2028 6 Rev. Ana. 1 EPS Ana. |
Dec 2029 7 Rev. Ana. 1 EPS Ana. |
Dec 2030 7 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
47.28B
est: 47.52B (-0.5%)
|
47.66B
est: 47.50B (+0.3%)
|
49.26B
est: 49.37B (-0.2%)
|
58.00B
est: 57.67B (+0.6%)
|
52.32B
est: 52.46B (-0.3%)
|
58.54B
est: 56.16B (+4.2%)
|
105.63B
est: 105.55B (+0.1%)
|
96.52B
est: 98.59B (-2.1%)
|
70.57B
est: 70.71B (-0.2%)
|
77.41B
est: 79.11B (-2.1%)
|
70.72B
est: 70.04B (+1.0%)
|
79.59B
77.19B – 81.99B
+13.6% YoY
|
78.52B
70.93B – 89.67B
-1.3% YoY
|
82.72B
77.37B – 90.02B
+5.4% YoY
|
61.41B
57.44B – 66.83B
-25.8% YoY
|
66.07B
61.80B – 71.90B
+7.6% YoY
|
| EBITDA |
9.70B
est: 2.66B (+265.1%)
|
5.40B
est: 2.66B (+103.1%)
|
11.54B
est: 2.76B (+318.1%)
|
9.27B
est: 3.23B (+187.4%)
|
2.18B
est: 2.93B (-25.6%)
|
-1.65B
est: 3.14B (-152.6%)
|
27.28B
est: 5.90B (+362.1%)
|
8.84B
est: 5.51B (+60.3%)
|
3.26B
est: 3.95B (-17.5%)
|
-6.83B
est: 5.01B (-236.2%)
|
644.00M
est: 4.44B (-85.5%)
|
5.04B
4.89B – 5.20B
+13.6% YoY
|
4.98B
4.50B – 5.68B
-1.3% YoY
|
5.24B
4.90B – 5.71B
+5.4% YoY
|
3.89B
3.64B – 4.24B
-25.8% YoY
|
4.19B
3.92B – 4.56B
+7.6% YoY
|
| EBIT |
7.58B
est: -253.32M (+3,091.3%)
|
2.53B
est: -253.21M (+1,101.1%)
|
8.51B
est: -263.17M (+3,334.0%)
|
6.19B
est: -307.44M (+2,113.5%)
|
-1.59B
est: -279.64M (-469.4%)
|
-6.01B
est: -299.37M (-1,906.3%)
|
22.51B
est: -562.67M (+4,100.8%)
|
4.10B
est: -525.57M (+880.5%)
|
-1.94B
est: -376.92M (-415.2%)
|
-11.78B
est: 300.14M (-4,024.5%)
|
-4.03B
est: 265.74M (-1,616.1%)
|
301.96M
292.87M – 311.05M
+13.6% YoY
|
297.90M
269.11M – 340.19M
-1.3% YoY
|
313.85M
293.55M – 341.54M
+5.4% YoY
|
233.00M
217.93M – 253.55M
-25.8% YoY
|
250.66M
234.45M – 272.77M
+7.6% YoY
|
| Net Income |
3.14B
est: 3.42B (-8.2%)
|
-411.47M
est: 2.75B (-115.0%)
|
4.08B
est: 4.21B (-3.0%)
|
2.87B
est: 3.34B (-14.3%)
|
-2.64B
est: -2.00B (-32.1%)
|
-7.02B
est: -4.26B (-64.8%)
|
13.99B
est: 15.83B (-11.7%)
|
-820.00M
est: 560.83M (-246.2%)
|
-4.58B
est: -3.51B (-30.3%)
|
-11.32B
est: -6.46B (-75.1%)
|
-9.88B
est: -1.41B (-601.9%)
|
-203.89M
-227.28M – -186.75M
+85.5% YoY
|
-1.21B
-1.35B – -1.11B
-492.5% YoY
|
-562.55M
-627.06M – -515.25M
+53.4% YoY
|
-1.01B
-1.13B – -928.16M
-80.1% YoY
|
198.70M
181.99M – 221.48M
+119.6% YoY
|
| SGA |
2.45B
est: 2.66B (-8.1%)
|
2.89B
est: 2.66B (+8.5%)
|
2.89B
est: 2.77B (+4.6%)
|
3.55B
est: 3.23B (+9.9%)
|
4.01B
est: 2.94B (+36.3%)
|
3.77B
est: 3.15B (+19.8%)
|
4.58B
est: 5.92B (-22.6%)
|
4.87B
est: 5.53B (-11.8%)
|
4.39B
est: 3.96B (+10.7%)
|
4.63B
est: 4.46B (+3.8%)
|
4.68B
est: 3.95B (+18.5%)
|
4.49B
4.35B – 4.62B
+13.6% YoY
|
4.43B
4.00B – 5.06B
-1.3% YoY
|
4.67B
4.36B – 5.08B
+5.4% YoY
|
3.46B
3.24B – 3.77B
-25.8% YoY
|
3.73B
3.49B – 4.06B
+7.6% YoY
|
| EPS |
3.77
est: 4.29 (-12.2%)
|
-0.52
est: 3.45 (-115.1%)
|
4.85
est: 5.28 (-8.2%)
|
3.60
est: 4.20 (-14.2%)
|
-3.32
est: -2.51 (-32.3%)
|
-8.81
est: -5.34 (-64.9%)
|
17.56
est: 19.87 (-11.6%)
|
-1.03
est: 0.70 (-246.4%)
|
-5.75
est: -4.41 (-30.5%)
|
-14.20
est: -8.11 (-75.1%)
|
-12.39
est: -1.77 (-601.7%)
|
-0.26
-0.29 – -0.23
+85.5% YoY
|
-1.52
-1.69 – -1.39
-492.5% YoY
|
-0.71
-0.79 – -0.65
+53.4% YoY
|
-1.27
-1.42 – -1.16
-80.1% YoY
|
0.25
0.23 – 0.28
+119.6% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C+ | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C+ | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C+ | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C+ | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C+ | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C+ | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | B- | 2/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C+ | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C+ | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C+ | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C+ | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C+ | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C+ | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C+ | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C+ | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C+ | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares MSCI Brazil Small-Cap ETF EWZS | 0.41% | 992.6K | 0.59% |
| 2 | FlexShares Morningstar Emerging Markets Factor Tilt Index Fund TLTE | 0.02% | 86.8K | 0.58% |
| 3 | iShares MSCI EM Small Cap UCITS ETF IEMS.L | 0.02% | 52.2K | 0.74% |
| 4 | iShares MSCI Emerging Markets Small-Cap ETF EEMS | 0.01% | 52.7K | 0.72% |
| 5 | State Street SPDR MSCI Emerging Markets Small Cap UCITS ETF EMSD.L | 0.01% | 76.8K | 0.55% |
| 6 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.01% | 75.6K | 0.65% |
| 7 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.01% | 1.50M | 0.06% |
| 8 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 37.1K | 0.48% |
| 9 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 4.13M | 0.06% |
| 10 | iShares Core MSCI EM IMI UCITS ETF EIMU.L | 0.00% | 33.7K | 0.18% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Daniel MacEachran | Head of Metabolic Engineering | — | — |
| Felipe Montoro Jens | Chief Financial & Investor Relations Officer | — | male |
| Geraldo Magela de Moraes Vilaca Netto | Executive Officer and Head of Legal, Corporate Governance & Intellectual Property | — | male |
| João Henrique Rittershaussen | Executive Officer and Head of Investments & Digital Technologies | — | male |
| Nir Lander | Vice President of People, Communication & Supply Chain | — | male |
| Roberto Prisco Paraíso Ramos | Chief Executive Officer | — | male |
| Rosana Avolio | Investor Relations Manager | — | female |
| Stefan Lanna Lepecki | Executive Officer & Head of South America Business | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for BRKM5.SA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
